GB Patent

GB9204808D0 — Novel compositions of matter

Assigned to Rhone Poulenc Rorer Ltd · Expires 1992-04-15 · 34y expired

What this patent protects

PCT No. PCT/GB93/00445 Sec. 371 Date Nov. 3, 1994 Sec. 102(e) Date Nov. 3, 1994 PCT Filed Mar. 4, 1993 PCT Pub. No. WO93/18024 PCT Pub. Date Sep. 16, 1993This invention is directed to 1-alkoxy-2-(alkoxy- or cycloalkyloxy-)-4-(cyclothioalkyl- or cyclothioalkenyl-)benzene compounds…

USPTO Abstract

PCT No. PCT/GB93/00445 Sec. 371 Date Nov. 3, 1994 Sec. 102(e) Date Nov. 3, 1994 PCT Filed Mar. 4, 1993 PCT Pub. No. WO93/18024 PCT Pub. Date Sep. 16, 1993This invention is directed to 1-alkoxy-2-(alkoxy- or cycloalkyloxy-)-4-(cyclothioalkyl- or cyclothioalkenyl-)benzene compounds that inhibit cyclic AMP phosphodiesterase or tumor necrosis factor (TNF) and are useful in treating patients suffering from disease state capable of being modulated by inhibiting production of cyclic AMP phosphodiesterase or TNF by administering the compound to the patient. The invention is also directed to the preparation of these compounds, pharmaceutical compositions containing these compounds and methods for their pharmaceutical use.

Drugs covered by this patent

Patent Metadata

Patent number
GB9204808D0
Jurisdiction
GB
Classification
—
Expires
1992-04-15
Drug substance claim
No
Drug product claim
No
Assignee
Rhone Poulenc Rorer Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.